Logotype for Medpace Holdings Inc

Medpace (MEDP) investor relations material

Medpace Q3 2025 earnings summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Medpace Holdings Inc
Q3 2025 earnings summary23 Oct, 2025

Executive summary

  • Q3 2025 revenue was $659.9 million, up 23.7% year-over-year, with net income of $111.1 million (+15.3%) and EBITDA of $148.4 million (+24.9%).

  • Net new business awards rose 47.9% to $789.6 million, with a net book-to-bill ratio of 1.20 and backlog reaching $3.0 billion (+2.5% YoY).

  • Backlog conversion rate increased to 23.0%, with $1.84 billion expected to convert to revenue in the next 12 months.

  • Growth was driven by strong performance in Metabolic, Oncology, and Central Nervous System therapeutic areas.

  • Pre-backlog (awarded but not yet started work) is up 30% year-over-year and now exceeds the size of the reported backlog.

Financial highlights

  • Year-to-date revenue as of September 30, 2025, was $1.82 billion (+15.9% YoY); year-to-date net income was $316.0 million.

  • Q3 2025 EBITDA margin was 22.5% (vs. 22.3% prior year); operating margin was 21.5%.

  • Diluted EPS for Q3 2025 was $3.86 (up from $3.01 in Q3 2024); year-to-date EPS was $10.64.

  • Cash and cash equivalents at quarter-end were $285.4 million; operating cash flow for the first nine months was $520.6 million.

  • No outstanding debt as of September 30, 2025.

Outlook and guidance

  • 2025 revenue guidance: $2.48–$2.53 billion (+17.6% to +20% YoY); EBITDA: $545–$555 million (+13.5% to +15.6% YoY); net income: $431–$439 million; EPS: $14.60–$14.86; effective tax rate: 18.25%–18.75%.

  • 2026 preliminary outlook: revenue growth in low double digits over updated 2025 guidance; EBITDA growth at high single-digit pace or greater.

  • Pass-through costs expected to remain high at 41–42% of revenue, with a potential peak in Q4 2025 and moderation in 2026.

  • Management expects to fund growth initiatives and capital needs through operating cash flow and available credit.

  • No additional share repurchases included in 2025 guidance.

Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.

Next Medpace earnings date

Logotype for Medpace Holdings Inc
Q4 202510 Feb, 2026
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next Medpace earnings date

Logotype for Medpace Holdings Inc
Q4 202510 Feb, 2026

The essential earnings season companion

The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

Medpace Holdings Inc., a full-service clinical research organization, provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers therapeutic expertise in the areas of endocrinology, gastroenterology, general medicine, hematology/oncology, infectious diseases/vaccines, and neuroscience.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage